iRemedy

STUART, FL – (GLOBE NEWSWIRE) – February 17, 2021 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that the Company has arranged for the procurement of an additional 500 million low-dead space syringes and needles in association with iRemedy’s “Project Vaccinate” initiative, created to support global demand for FDA-approved injection devices required for administration of COVID-19 vaccinations.

STUART, FL – (GLOBE NEWSWIRE) – February 17, 2021 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that in association with the Company’s effort to procure and deliver one billion FDA-approved hypodermic needles and syringes in support of COVID-19 vaccination programs worldwide, over 130 million units have been delivered to customers since announcing its program in November 2020.

STUART, FL – November 18, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that in anticipation of COVID-19 vaccines becoming available soon, the Company has procured factory capacity for production of over one billion, FDA-approved hypodermic needles and syringes that will be required for administration of vaccinations to the public on a global basis.

STUART, FL – September 21, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, today announced that a total of 50 care box donations have now been shipped to underserved, underfunded community medical centers and clinics in association with iRemedy’s Project Restart program launched in early August 2020.

STUART, FL – August 24, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, today announced that over the past week, the Company has shipped Project Restart ‘care boxes’ to 15 more community care organizations providing care to patients in underserved, underprivileged communities and neighborhoods in the U.S.; bringing the total to over 21 shipments since the program’s launch on August 5, 2020.

STUART, FL – August 13, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, announced that the launch of Project Restart earlier this month has been received with great enthusiasm and is already having positive impact on community care providers across the country.

STUART, FL – August 5, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, today announced the formation of Project Restart, an initiative to help address the severe shortage of medical supplies in demand by local, underfunded community health centers and clinics.

Brothers Tony and Gary Paquin started incubating iRemedy 15 years ago with the idea that retail products and services would be the next wave in healthcare. They founded Paquin Healthcare Companies to educate the U.S. healthcare industry on how to adapt and engage patients with retail models and technologies. In 2009, Tony’s book,“The Retail Healthcare Revolution”, laid out strategies for how healthcare institutions could get in on the consumer-driven market for products and services—and urged them to do so to remain profitable.

Even in a time of crisis and product shortages, we know you’ve got options when it comes to medical supplies. When you place your trust in iRemedy, we absolutely guarantee customer satisfaction. It’s a promise we can deliver on because we don’t believe in doing business as usual. We’ve created an entirely new approach.

The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, and Verséa Holdings, a U.S.-based healthcare company focused on clinical research and novel scientific discoveries and products, today jointly announced the commercial availability of a COVID-19 Rapid Test Serology Kit that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for administration by U.S. healthcare providers in testing patients for coronavirus infection.